Nonalcoholic Steatohepatitis (NASH)
Topics
<< < (4/7) > >>
[1] Tropifexor Shows Promise as Treatment for NASH
[2] Emricasan Proves a Disappointment as NASH Treatment
[3] Selonsertib Fails to Improve NASH-Related Fibrosis
[4] Machine Learning Tool Can Predict Risk of Fatty Liver Disease
[5] New MRI Contrast Dye Better Detects Early-Stage Liver Disease
[6] Rise in Obesity Will Fuel Need for NASH-Related Liver Transplants
[7] Experimental NASH Drug Fails in Late-Stage Study
[8] Disappointing Midway Trial Results for Emricasan as Treatment for NASH
[9] First Large Study Shows Liver Fibrosis Improvement in People With NASH
Navigation
[0] Up one level
[#] Next page
[*] Previous page